Jeanne Eagels

NIKOLA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Nikola Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, December 9, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Nikola Corporation (“Nikola” or the “Company”) (NASDAQ: NKLA) in the United States District Court for the District of Arizona on behalf of all persons and entities who purchased or otherwise acquired Nikola securities between February 24, 2022 and September 7, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Nikola Corporation (“Nikola” or the “Company”) (NASDAQ: NKLA) in the United States District Court for the District of Arizona on behalf of all persons and entities who purchased or otherwise acquired Nikola securities between February 24, 2022 and September 7, 2023, both dates inclusive (the “Class Period”).
  • Investors have until December 12, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • There is no cost or obligation to you.

MICROVAST ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Microvast Holdings, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, December 8, 2023

Investors have until February 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until February 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Polyaramid is a high-temperature resistant synthetic polymer, and a polyaramid separator is an insulating film used in high-capacity lithium-ion batteries.
  • On May 22, 2023, after the market closed, Reuters reported the DOE would not award Microvast the Grant.
  • In a call with congressional staff that evening, the DOE confirmed negotiations with Microvast concerning the Grant had been cancelled.

ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, December 7, 2023

Our investigation concerns whether the board of directors of Organogenesis have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Organogenesis have breached their fiduciary duties to the company.
  • On October 12, 2021, Value Investors Club issued a report alleging issues at Organogenesis Holdings, Inc., indicating that the wound care medical company has been improperly billing the federal government for $250 million annually.
  • The Company also set the price for its new wound covering, Affinity, “exorbitantly high,” which Medicare reimbursed, while making the product lucrative for doctors to use through large rebates.
  • On this news, shares of Organogenesis fell over 18% in intraday trading on October 12, 2021.

KENVUE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kenvue Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, December 7, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Kenvue securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Kenvue’s initial public offering (the “IPO” or “Offering”).

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Kenvue securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Kenvue’s initial public offering (the “IPO” or “Offering”).
  • Investors have until December 8, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • There is no cost or obligation to you.

BLUE RIDGE BANKSHARES ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Blue Ridge Bankshares, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, December 6, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Blue Ridge Bankshares, Inc. (“Blue Ridge Bankshares” or the “Company”) (NYSE American: BRBS) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Blue Ridge Bankshares securities between March 10, 2023 and October 31, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Blue Ridge Bankshares, Inc. (“Blue Ridge Bankshares” or the “Company”) (NYSE American: BRBS) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Blue Ridge Bankshares securities between March 10, 2023 and October 31, 2023, both dates inclusive (the “Class Period”).
  • Investors have until February 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • There is no cost or obligation to you.

APPLIED DIGITAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Applied Digital Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, December 6, 2023

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Applied Digital Corporation (NASDAQ: APLD) on behalf of long-term stockholders following a class action complaint that was filed against Applied Digital on August 12, 2023 with a Class Period from April 13, 2022 to July 26, 2023.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Applied Digital Corporation (NASDAQ: APLD) on behalf of long-term stockholders following a class action complaint that was filed against Applied Digital on August 12, 2023 with a Class Period from April 13, 2022 to July 26, 2023.
  • Our investigation concerns whether the board of directors of Applied Digital have breached their fiduciary duties to the company.
  • According to the filed complaint, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
  • There is no cost or obligation to you.

EHANG ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against EHang Holdings Limited and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, December 5, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against EHang Holdings Limited (“EHang” or the “Company”) (NASDAQ: EH) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired EHang securities between January 20, 2022 and November 6, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against EHang Holdings Limited (“EHang” or the “Company”) (NASDAQ: EH) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired EHang securities between January 20, 2022 and November 6, 2023, both dates inclusive (the “Class Period”).
  • Investors have until February 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • There is no cost or obligation to you.

LIVEPERSON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against LivePerson, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, December 5, 2023

Investors have until January 30, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 30, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • According to the filed complaint, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects.
  • There is no cost or obligation to you.

COMERICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Comerica Incorporated on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, December 4, 2023

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Comerica Incorporated (NYSE: CMA) on behalf of long-term stockholders following a class action complaint that was filed against Comerica on August 21, 2023 with a Class Period from February 9, 2021 to May 29, 2023.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Comerica Incorporated (NYSE: CMA) on behalf of long-term stockholders following a class action complaint that was filed against Comerica on August 21, 2023 with a Class Period from February 9, 2021 to May 29, 2023.
  • Our investigation concerns whether the board of directors of Comerica have breached their fiduciary duties to the company.
  • When the true details entered the market, the lawsuit claims that investors suffered damages.
  • There is no cost or obligation to you.

EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Eagle Pharmaceuticals, Inc. on Behalf of Eagle Pharmaceuticals Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, December 2, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Eagle Pharmaceuticals, Inc. (“Eagle Pharmaceuticals” or the “Company”) (NASDAQ: EGRX) on behalf of Eagle Pharmaceuticals stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Eagle Pharmaceuticals, Inc. (“Eagle Pharmaceuticals” or the “Company”) (NASDAQ: EGRX) on behalf of Eagle Pharmaceuticals stockholders.
  • Our investigation concerns whether Eagle Pharmaceuticals has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On November 9, 2023, Eagle issued a press release stating that “it will be delaying the release of its third quarter 2023 results and investor conference call, previously scheduled for today .
  • The Company requires more time to review potential adjustments relating to the reporting of sales of PEMFEXY(R) prior to filing its Form 10-Q.